Canaccord Genuity Starts Aptose Biosciences (APTO) at Buy
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Price: $1.71 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Aptose Biosciences (NASDAQ: APTO) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Aptose Biosciences click here. For more ratings news on Aptose Biosciences click here.
Shares of Aptose Biosciences closed at $7.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Canaccord Starts Kazia Therapeutics (KZIA) at Buy
- Goldman Sachs Starts Vail Resorts (MTN) at Sell
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
